Junior Group Leader
My group aims to develop new radioisotope-labelled compounds for the imaging of tumour biology.
Bart is CRUK Junior Group Leader based at the Oxford Institute for Radiation Oncology and has headed the Radiopharmaceuticals and Molecular Imaging group since early 2013.
Bart trained in analytical chemistry and radiochemistry at the Universities of Hasselt and Ghent, Belgium. He obtained his PhD in radiopharmaceutical sciences from the University of Ghent and spent several years at the University of Toronto as a post-doctoral fellow before joining the University of Oxford in 2007 as a postdoctoral researcher in Professor Kate Vallis’ group.
Group Alumni & Next Destinations
James Knight, Postdoctoral Researcher - Newcastle University
O'Neill E. et al, (2019), J Nucl Med
Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling
CORNELISSEN B. et al, (2019), The Journal of Nuclear Medicine
Development of novel Ga-68 chelators for PET imaging
Sneddon D. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S728 - S729
Imaging [F-18]olaparib in malignant glioma models
Hopkins SL. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S685 - S685
Imaging DNA Damage in vivo following [Lu-177] Lu-DOTATATE therapy in a model of pancreatic neuroendocrine cancer
O'Neill E. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S196 - S196